HIGHLIGHTS
- who: CRISPR/Cas and collaborators from the Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Department of Pediatrics, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan have published the paper: Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo, in the Journal: (JOURNAL)
- what: This study demonstrated the critical role of the gene in maintaining cell survival and tumorigenicity in vitro and in vivo. gene editing-based therapy might provide a potential strategy for imatinib-insensitive or resistant patients. The authors aimed to investigate the anticancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.